MétaCan
Menu
Back to cohort
Record W4226247856 · doi:10.1002/alz.057528

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

2021· article· en· W4226247856 on OpenAlexaff
Constance Delaby, Charlotte E. Teunissen, Kaj Blennow, Daniel Alcolea, Ivan Arisi, Élodie Bouaziz-Amar, Anne Beaume, Aurélie Bedel, Giovanni Bellomo, Edith Bigot‐Corbel, Maria Bjerke, M Blanc, Merçé Boada, Olivier Bousiges, Miles Chapman, Mari L. DeMarco, Mara D’Onofrio, Julien Dumurgier, Diane Dufour‐Rainfray, Sebastiaan Engelborgs, Hermann Esselmann, Anne Fogli, Audrey Gabelle, Elisabetta Galloni, Clémentine Gondolf, Frédérique Grandhomme, Oriol Grau‐Rivera, Melanie Hart, Takeshi Ikeuchi, Andreas Jeromin, Kensaku Kasuga, Ashvini Keshavan, Michael Khalil, Pèter Köertvelyessy, Agnieszka Kulczyńska‐Przybik, Jean Laplanche, Piotr Lewczuk, Qiao‐Xin Li, Alberto Lleó, Catherine Malaplate, Marta Marquié, Colin L. Masters, Barbara Mroszko, Léonor Nogueira, Adelina Orellana, Markus Otto, Jean‐Baptiste Oudart, Claire Paquet, Federico Paolini Paoletti, Lucilla Parnetti, Armand Perret‐Liaudet, Katell Poec’h, Koen Poesen, Albert Puig‐Pijoan, Isabelle Quadrio, Muriel Quillard‐Muraine, Benoît Rucheton, Susanna Schraen‐Maschke, Jonathan M. Schott, Leslie M. Shaw, Marc Suárez‐Calvet, Magda Tsolaki, Hayrettin Tumani, Chinedu Udeh‐Momoh, Lucie Vaudran, Marcel M. Verbeek, Federico Verde, Lisa Vermunt, Jonathan Vogelgsang, Jens Wiltfang, Henrik Zetterberg, Sylvain Lehmann

Bibliographic record

VenueAlzheimer s & Dementia · 2021
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsSt. Paul's HospitalUniversity of British ColumbiaProvidence Health Care
Fundersnot available
KeywordsContext (archaeology)BiomarkerMedicineCerebrospinal fluidHarmonizationStandardizationDiseaseInterpretation (philosophy)Diagnostic accuracyPsychologyMedical physicsPathologyIntensive care medicineInternal medicineComputer scienceChemistryBiology

Abstract

fetched live from OpenAlex

Abstract Background The quantification of cerebrospinal fluid (CSF) biomarkers (Amyloid beta peptides [Aß1‐40 and Aß1‐42], t‐tau and p‐tau(181)) is progressively implemented in specialized laboratories as an aid for the multidisciplinary diagnosis of Alzheimer’s disease (AD). There is however a diversity of practices between centers related to pre‐analytical and analytical conditions, the calculation of ratios between analytes, the applied cut‐off, or the use of interpretation scales. Finally, for the same biochemical profile, the interpretation and reporting of results may differ from one center to another, which may raise questions about the commutability of the tests. So far, no consensus has been reached between the different laboratories involved to define the most appropriate conclusions/comments based on the profile of the quantified biomarkers. This work is an essential step towards a consensual harmonization of clinical reporting after CSF analysis in the context of AD diagnosis, as advocated by the "Biofluid Based Biomarkers PIA" working group of the Alzheimer's Association. Method We obtained, by means of a questionnaire, a description of the pre‐analytical and analytical protocols and examples of reporting from 40 centers located in 15 countries, i.e. in the majority of countries that have implemented clinical CSF tests for the diagnosis of AD. We then adopted a consensus approach to propose harmonized comments corresponding to different AD CSF biomarker profiles observed in patients. Result Pre‐analytical procedures were very similar, among the centers. Regarding the analytical part, more than 88% of the laboratories use automatized immunoassays and more than 83% measure Aß1‐40 and compute the Aß1‐42/Aß1‐40 ratio, in addition to the three core biomarkers (Aß1‐42, t‐tau and p‐tau(181)). The cut‐off values of biomarkers used by the different laboratories are widely dispersed. Delay before sending back the results is lower than 1 week in more than 34% of the laboratories. Conclusion Our results highlight the state of the art in terms of clinical CSF analysis in the context of AD. Harmonization of clinical reporting between different centers could benefit AD care, prevention and treatment strategies, as a common terminology will allow a better assessment of the prevalence of AD and the contribution of biochemical biomarkers to its diagnosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.126
metaresearch head score (Gemma)0.135
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.126
Threshold uncertainty score0.664

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1260.135
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0140.016
Science and technology studies0.0010.005
Scholarly communication0.0060.006
Open science0.0040.007
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.127
GPT teacher head0.425
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicAlzheimer's disease research and treatmentsFrench-language works237,207